Dr. Caralee Caplan-shaw, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 8175 Nw 12th St, Suite 306, Doral, FL 33126 Phone: 786-845-0164 Fax: 786-845-0176 |
News Archive
In a Los Angeles Times opinion piece, Evan Wood, associate professor of medicine at the University of British Columbia, writes about the Vienna Declaration, a document he helped to draft, that calls for international leaders to revise drug policies to incorporate greater scientific evidence and promote HIV prevention, treatment and care for drug users.
In five randomized controlled trials involving 457 people, the authors report that for patients treated with methotrexate, as a single therapy or in combination with other drug treatment, pooled data showed a tendency toward an increased risk of death or liver transplantation. The brand names for methotrexate are Rheumatrex and Trexall.
Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced its third quarter 2010 financial results as well as recent clinical and operational achievements.
The use of arsenic trioxide instead of idarubicin in combination with all-trans retinoic acid is a feasible option in patients with acute promyelocytic leukaemia, regardless of risk level, suggests a phase III trial.
Covidien, a leading global provider of healthcare products, and Nuvo Research Inc. (TSX:NRI), a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid® Topical Solution (diclofenac sodium topical solution) 1.5% w/w.
› Verified 9 days ago